In recent years, highly sensitive "sandwich"-type immunoassays, with use of monoclonal antibodies, have been developed for determining thyrotropin (TSH) concentrations.' Such assays lowered the limit of detection and modified the strategy for routine thyroid examination. Particularly, the suppressed TSH concentrations associated with hyperthyroidism are more clearly distinguished from the lower limit of the euthyroid TSH range. These two-site procedures have been based on radiometric (1-4), fluorometnc (5), immunoenzymometric (6), and chemiluminometric (7) assays.
Materials and Methods

Analytical Procedures
Immunochemiluminometric assay for TSH. The Magic Lite TSH assay includes two anti-TSH monoclonal antibodies, one immobilized on paramagnetic particles and the other directly labeled with acridinium ester (the signal reagent). Each is specific to different epitopes on the intact TSH molecule. In the assay, 100 1.LLof serum is incubated with 100 p.L of "Lite" reagent (acridinium-ester-labeled antibody) for 2.5 h at room temperature. After addition of 500 p.L of solid phase and incubation at room temperature for 30 mm, bound and free labeled antibody are magnetically separated and the TSH is quantified at the rate of lOs per sample. Oxidation of acridinium ester by alkaline hydrogen peroxide, automatically performed in the Magic Lite analyzer, initiates chemiluminescence emission. The manufacturer has informed us that, at the concentration used in the test (<5 parts per billion), the acridinium conjugate and the products of the chemiluminescence reaction have shown no mutagenicity in an Ames test as performed by an independent testing laboratory.
The light emission is expressed as photon counts accumulated during 2 s (relative light unit, RLU). Only two TSH calibrators (standardized against the second International Reference Preparation, 2nd IRP, coded 80/558) are required in each assay: one low calibrator (0 milli-int. unitlL) and one high calibrator (approximately 16 milli-int. units/L). Their RLU values in each assay are used to re-calibrate a manufacturer-generated Master Curve, which is stored in the analyzer's memory for each lot of reagents. The re-calibration takes place via algorithms in the analyzer software, which transform the spline of the Master Curve. We performed all assays of calibrators and unknown samples in duplicate.
Immunoradiometric and immunofluoroinetric assays for TSH. We compared results obtained with the Magic Lite TSH assay with those of a immunoradiometric assay (IRMA; "RIA Gnost hTSH" from Hoechst-Behring, Frankfurt, F.R.G.) and with our routine test, the immunofluorometric assay (IRMA; "hTSH Delfia" from LKB, Bromma, Sweden). These two methods are also "sandwich"-type techniques involving two monoclonal antibodies. Standards are calibrated against the 2nd International Reference Preparation for the nuss and against the First International Reference Preparation, 1st IRP coded 68/38, for the IFMA. Other assays. Concentrations of free thyroxin (FF4) and free triiodothyromne (FF3) were measured with a chromatographic method (Sclavo,Siena, Italy). Normal reference intervals for FF4 and FF3 were 8 to 15 pmol/L and 4 to 7 pmoLIL, respectively.
Clinical Evaluation
Patients. The population we studied comprised all subjects who were being routinely assessed for thyroid function during two months (n = 388). In each case the diagnosis was established on the basis of clinical examination, measure-
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Results
Analytical Variables
Precision. For evaluation of precision within-and between-run, we prepared pools of human serum with TSH concentrations ranging from 0.05 to 29 milli-int. units/L. As expected, the CVs are highest for pools with the lowest concentrations of TSH. Intra-batch CVs (n = 10) were 12%, 7%, 5%, 4.5%, 2.5%, 2.5%, and 3% for TSH values of 0.06,. 0.34, 1.22, 6.8, 13.4, and 29 milli-int. unitsfL, respectively. Inter-batch CVs (n = 23) were 57%, 15%, 9.5%, and 9% for TSH values of 0.04, 0.18, 2.8, and 13.7 milli-int. unitsfL, respectively. We observed similar results with IRMA and WMA (Figure 1) .
Detection limits. By extrapolating the intra-assay precision profile C = flC) (absolute error vs concentration, with = 2 SD), we derived the limit of detection as 0.01 milliint. unit/L. We observed the same value when a low-TSH sample (0.3 milli-int. unitfL) was diluted with "zero"-TSH serum from a hyperthyroid patient (Figure 2 ). When estimated from the inter-assay precision profile, the limit of detection was 0.04 milli-int. unit/L. This latter value is more consistent with the conditions obtaining in a routine laboratory (different lots of reagents, different technicians, etc.). Detection limits obtained under the same conditions by the uu& and WMA methods were also about 0.01 miui-int. unitI L (intra-assay) and 0.04 milli-int. unitlL (inter-assay).
Linearity. Three patients' samples, containing 104, 11, and 0.3 milli-int. unitsfL, when serially diluted with serum from a hyperthyroid individual, gave log-linear responsesto dilution down to the limit of detection. Intra-assay drift. No significant intra-assay drift (Student's paired t-test: t = 0.12, n = 10, not significant) was observed when the same sample was positioned at the beginning and the end of 10 consecutive runs containing up to 100 tubes each.
Matrix effect. Moderately hemolyzed samples (2.8 to 13.6 g of hemoglobin per liter) averaged slightly higher TSH values for percentage recovery than unhemolyzed: (hemolyzed TSHlunhemolyzed TSH) x 100% = 112% (SD 13%; n = 16). There was no correlation between increasing hemoglobin concentration and increased TSH (recovery, % = 0.38 Hb + 110, r = 0.08, n = 16). No change in TSH concentration was observed between hemolyzed and unhemolyzed "zero"-TSH serum. However, hemolysis reflects mistreatment of the sample and results should be interpreted 
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Count ratevsexpectedTSH values for a sampledilutedwith the 'zero"-TSHserum of an hyperthyroid patient The limit ofdetectionis about0.01 mull-mt. unlt/t.,the point ofintersection between the dikitloncurve andthe hyperthyroid serum count-rate line (mean % recovery = 92%) and biirubin-supplemented (mean % recovery = 97%) samples. 'Two-point calibration" validity ( Figure 3) . We measured TSH concentrations in 63 samplesin two different runs. The first was performed using the Magic Lite "two-point calibration" system. In the second assay, the standard curve was obtained from an included-in-the-run set of seven TSH standard preparations (range 0 to 100 milli-int. units/L) supplied by Ciba Corning. Identical results were observed by the two me.thods for TSH concentrations below 5 millimt.units/L; the regression equation for the relation was y = 0.93x -0.01 (Student's paired t-test, t = 1.5; not significant). For TSH >5 milli-int. unitsIL, the results by the "two-point calibration" system were significantly higher than those obtained with the full set of standards (y = 1.24x -1.44, t =
3.3; P <0.01).
Comparison with ir and u (Figure 4) . Basal TSH concentrations for the 388 subjects were assayed by the three methods. Linear regression analysis for TSH concentrations as measured with the ICMA (y), nu (x), and IFMA (x') methods gave y = 1.04x -0.11 (r = 0.975, n = 371, P <0.001) and y = 1.26x' + 0.09 (n = 388, r = 0.975, P <0.001). The correlation coefficients confirmed the evidently unitsIL) by isa. The distribution of TSH ic concentrations in euthyroid (group 1), hyperthyroid (group 2), and hypothyroid populations (group 3) is shown in Figure 5 .
Of the 33 hyperthyroid patients, 16 had basal TSH while the others ranged from 0.04 to 0.14 milli-int. unitiL; values for the three patients treated with neomercazole were 0.05, 0.09, and 0.14 milli-int. unitsfL.
Basal TSH concentrations of the 51 hypothyroid patients ranged between 2 and 65 milli-int. units/L; 13/51 were within the euthyroid reference interval, their hypothyroid state was confirmed by an exaggerated response to TRH stimulation (>30 milli-int. unitsfL); 10 of them were subclinically hypothyroid. Seven low TSH concentrations (below the lower limit of the euthyroid reference interval) were observed in the euthyroid population (group 1).
The same kind of distributions were observed with IFMA and uu ( Figure 6 ). However, slight differences with IcMA can be pointed out: (a) In 17 of 33 hyperthyroid patients, data were above the detection limit by ICMA, with 2/33 and 4/29 above the detection limits by rmtA and IRMA, respectively. Technical errors were excluded by repeating samples in another assay. The TSH stimulation test was performed for eight of these 17 patients: five gave a low but significant response (i.e., TSH >0.04 milli-int. unitlL); only 2/8 gave significant responses with the two other methods.(b) Of the 14/176 (IFMA) and 7/174 (HIMA) euthyroid subjects with low basal TSH concentrations, three (irMA) and two (IRMA) were below the limit of detection. In contrast, of the seven low-TSH euthyroid subjects by ic, none showed an undetectable concentration of TSH. Such differences could suggest that the ICMA assay measures "TSH fractions" undetectable by the two other techniques. Further investigations will be required to confirm these results.
Discussion
We found the immunochemiluminometric assay of TSH easy to use and reliable. In the Magic Lite assay, the chemiluminescent compound is directly attached to an antibody; there is no need for a secondary reaction, such as an enzymatic one, to initiate the chemiluminescent signal. The long counting time of a sensitive immunoradiometric assay is not required because of the high specific activity of the chemihumnescent-labeled analyte. Each labeled molecule potentially generates one "event" (one photon emitted). In practice, only about 10% of these emit light. However, this is much greater than with 'I labeling, where there is one event per second for 7.5 x 106 molecules of label. With the Magic Lite system, full standard curves are eliminated; only a simple two-point calibration is necessary. We found, in a single experiment, that results obtained by using two-point calibration compared well with results obtained by using full standardization for TSH concentrations <5 milli-int. urnts/L. We found also that this system gives a slight overestimation for TSH concentrations >5 miui-int. unitWL; this is obviously without clinical repercussion because basal NH concentrations >5 milli-int. units/L correspond to hypothyroid patients. The two-point calibration system simplifies every assay and cuts down on reagent use and operator hands-on time. Small runs can be made cost effective to generate results for just a few patients.
Our analytical evaluation indicated excellent performances of the immunochemiluminometric system for TSH: within-and between-run reproducibilities, limit of detection, linearity, recovery, no matrix effect, and good correlations with the IRMA and IFIvIA methods. The lower results we obtained by the wr& assay may be attributed to differences in the calibration system for the TSH standards.
Clinical evaluation showed that TSH by ic is a valuable tool in the assessment of hyperthyroidism.
Taking 0.2 milli-int. unit/L as the upper TSH concentration in hyper-thyroidism, the clinical sensitivity of the TSH ICMA was 100% (TSH <0.2 milli-int. urnt/L for all of our hyperthyroid patients) and its clinical specificity was 98% (percentage of euthyroid subjects with a basal TSH >0.2 milli-int. unitlL).
We conclude that the immunochemiluminometric assay from Ciba Corning Diagnostics is accurate and precise for the measurement of TSH. This "Magic Lite System" is efficient and reliable for use in routine screening for thyroid function.
We are grateful to Ciba Corning Diagnostics Corp. for lendingus the instrumentation and donating the reagent kits used in this evaluation.
